80 related articles for article (PubMed ID: 25953331)
1. Biodistribution of size-selected lyophilisomes in mice.
van Bracht E; Raavé R; Perevyazko IY; Versteeg EM; Hafmans TG; Schubert US; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2015 Aug; 94():141-51. PubMed ID: 25953331
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.
van Bracht E; Stolle S; Hafmans TG; Boerman OC; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2014 May; 87(1):80-9. PubMed ID: 24463217
[TBL] [Abstract][Full Text] [Related]
3. Lyophilisomes as a new generation of drug delivery capsules.
van Bracht E; Raavé R; Verdurmen WP; Wismans RG; Geutjes PJ; Brock RE; Oosterwijk E; van Kuppevelt TH; Daamen WF
Int J Pharm; 2012 Dec; 439(1-2):127-35. PubMed ID: 23069914
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
5. Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles.
Mérian J; Boisgard R; Bayle PA; Bardet M; Tavitian B; Texier I
Eur J Pharm Biopharm; 2015 Jun; 93():1-10. PubMed ID: 25805562
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J
Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221
[TBL] [Abstract][Full Text] [Related]
7. Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting.
Hirsjärvi S; Sancey L; Dufort S; Belloche C; Vanpouille-Box C; Garcion E; Coll JL; Hindré F; Benoît JP
Int J Pharm; 2013 Sep; 453(2):594-600. PubMed ID: 23747436
[TBL] [Abstract][Full Text] [Related]
8. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
9. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Cho M; Cho WS; Choi M; Kim SJ; Han BS; Kim SH; Kim HO; Sheen YY; Jeong J
Toxicol Lett; 2009 Sep; 189(3):177-83. PubMed ID: 19397964
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
11. An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation.
Paoli EE; Kruse DE; Seo JW; Zhang H; Kheirolomoom A; Watson KD; Chiu P; Stahlberg H; Ferrara KW
J Control Release; 2010 Apr; 143(1):13-22. PubMed ID: 20006659
[TBL] [Abstract][Full Text] [Related]
12. Design of dye and superparamagnetic iron oxide nanoparticle loaded lipid nanocapsules with dual detectability in vitro and in vivo.
Bohley MS; Birch E; Baumann FJ; Dillinger AE; Tamm ER; Goepferich AM
Int J Pharm; 2020 Jul; 585():119433. PubMed ID: 32447023
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors.
Beloqui A; Solinís MA; Delgado A; Evora C; del Pozo-Rodríguez A; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2013 Jun; 84(2):309-14. PubMed ID: 23461861
[TBL] [Abstract][Full Text] [Related]
14. Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles.
Rodrigues D; Freitas M; Marisa Costa V; Arturo Lopez-Quintela M; Rivas J; Freitas P; Carvalho F; Fernandes E; Silva P
Nanotoxicology; 2017 Mar; 11(2):256-266. PubMed ID: 28166432
[TBL] [Abstract][Full Text] [Related]
15. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
16. Nanoerythrosomes, a new derivative of erythrocyte ghost: IV. Fate of reinjected nanoerythrosomes.
Désilets J; Lejeune A; Mercer J; Gicquaud C
Anticancer Res; 2001; 21(3B):1741-7. PubMed ID: 11497254
[TBL] [Abstract][Full Text] [Related]
17. Boron nitride nanotubes radiolabeled with ⁹⁹mTc: preparation, physicochemical characterization, biodistribution study, and scintigraphic imaging in Swiss mice.
Soares DC; Ferreira TH; Ferreira Cde A; Cardoso VN; de Sousa EM
Int J Pharm; 2012 Feb; 423(2):489-95. PubMed ID: 22178127
[TBL] [Abstract][Full Text] [Related]
18. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats.
Kutscher HL; Chao P; Deshmukh M; Singh Y; Hu P; Joseph LB; Reimer DC; Stein S; Laskin DL; Sinko PJ
J Control Release; 2010 Apr; 143(1):31-7. PubMed ID: 20043961
[TBL] [Abstract][Full Text] [Related]
19. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation.
Kaur A; Jain S; Tiwary AK
Acta Pharm; 2008 Mar; 58(1):61-74. PubMed ID: 18337208
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and pharmacological characterization of alpha-tocopherol-loaded nano-emulsion system.
Hatanaka J; Chikamori H; Sato H; Uchida S; Debari K; Onoue S; Yamada S
Int J Pharm; 2010 Aug; 396(1-2):188-93. PubMed ID: 20558261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
